Dingdang Health executes HK$1.43 million buyback; 29.21 million shares now pending cancellation

Bulletin Express04-02

Dingdang Health Technology Group Ltd. announced that on 2 April 2026 it repurchased 1.52 million ordinary shares on the Hong Kong Stock Exchange at HK$0.93–0.94 per share, spending HK$1.43 million. All shares are earmarked for cancellation.

The latest transaction lifts the total number of shares repurchased but not yet cancelled to 29.21 million since the current programme began on 25 November 2025. This volume represents 2.21% of the company’s issued share capital at the time the mandate was approved and utilises 22.14% of the 131.95 million-share authorisation granted on 28 May 2025.

Outstanding issued shares remain unchanged at 1.32 billion, as the repurchased shares have not yet been cancelled and Dingdang Health holds no treasury shares. Under Hong Kong listing rules, the company is subject to a moratorium on new share issues until 2 May 2026 following the latest buyback.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1118272035?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 18:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118272035","market":"us","top_or_hot":-1,"title":"Dingdang Health executes HK$1.43 million buyback; 29.21 million shares now pending cancellation","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. announced that on 2 April 2026 it repurchased 1.52 million ordinary shares on the Hong Kong Stock Exchange at HK$0.93–0.94 per share, spending HK$1.43 million. All shares are earmarked for cancellation.</p>\n<p>The latest transaction lifts the total number of shares repurchased but not yet cancelled to 29.21 million since the current programme began on 25 November 2025. This volume represents 2.21% of the company’s issued share capital at the time the mandate was approved and utilises 22.14% of the 131.95 million-share authorisation granted on 28 May 2025.</p>\n<p>Outstanding issued shares remain unchanged at 1.32 billion, as the repurchased shares have not yet been cancelled and Dingdang Health holds no treasury shares. Under Hong Kong listing rules, the company is subject to a moratorium on new share issues until 2 May 2026 following the latest buyback.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health executes HK$1.43 million buyback; 29.21 million shares now pending cancellation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health executes HK$1.43 million buyback; 29.21 million shares now pending cancellation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 18:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. announced that on 2 April 2026 it repurchased 1.52 million ordinary shares on the Hong Kong Stock Exchange at HK$0.93–0.94 per share, spending HK$1.43 million. All shares are earmarked for cancellation.</p>\n<p>The latest transaction lifts the total number of shares repurchased but not yet cancelled to 29.21 million since the current programme began on 25 November 2025. This volume represents 2.21% of the company’s issued share capital at the time the mandate was approved and utilises 22.14% of the 131.95 million-share authorisation granted on 28 May 2025.</p>\n<p>Outstanding issued shares remain unchanged at 1.32 billion, as the repurchased shares have not yet been cancelled and Dingdang Health holds no treasury shares. Under Hong Kong listing rules, the company is subject to a moratorium on new share issues until 2 May 2026 following the latest buyback.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1118272035","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118272035","pubTimestamp":1775125557,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. announced that on 2 April 2026 it repurchased 1.52 million ordinary shares on the Hong Kong Stock Exchange at HK$0.93–0.94 per share, spending HK$1.43 million....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康执行143万港元回购；2921万股目前等待注销","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. announced that on 2 April 2026 it repurchased 1.52 million ordinary shares on the Hong Kong Stock Exchange at HK$0.93–0.94 per share, spending HK$1.43 million. All shares are earmarked for cancellation.\nThe latest transaction lifts the total number of shares repurchased but not yet cancelled to 29.21 million since the current programme began on 25 November 2025. This volume represents 2.21% of the company’s issued share capital at the time the mandate was approved and utilises 22.14% of the 131.95 million-share authorisation granted on 28 May 2025.\nOutstanding issued shares remain unchanged at 1.32 billion, as the repurchased shares have not yet been cancelled and Dingdang Health holds no treasury shares. Under Hong Kong listing rules, the company is subject to a moratorium on new share issues until 2 May 2026 following the latest buyback.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118272035","isCrawlerRequest":true}